TSX:CPH - Toronto Stock Exchange - CA17253X1050 - Common Stock - Currency: CAD
Taking everything into account, CPH scores 6 out of 10 in our fundamental rating. CPH was compared to 33 industry peers in the Pharmaceuticals industry. While CPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CPH is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make CPH a good candidate for growth investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.67% | ||
ROE | 8.79% | ||
ROIC | 3.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 18.39% | ||
PM (TTM) | 23.4% | ||
GM | 71.95% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.38 | ||
Debt/FCF | N/A | ||
Altman-Z | 3.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.28 | ||
Quick Ratio | 1.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.96 | ||
Fwd PE | 12.82 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 20.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
TSX:CPH (7/23/2025, 7:00:00 PM)
12.72
+0.37 (+3%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.96 | ||
Fwd PE | 12.82 | ||
P/S | 6.07 | ||
P/FCF | N/A | ||
P/OCF | 11.25 | ||
P/B | 2.28 | ||
P/tB | 22.25 | ||
EV/EBITDA | 20.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.67% | ||
ROE | 8.79% | ||
ROCE | 4.99% | ||
ROIC | 3.6% | ||
ROICexc | 4.24% | ||
ROICexgc | 18.03% | ||
OM | 18.39% | ||
PM (TTM) | 23.4% | ||
GM | 71.95% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.38 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 3.14 | ||
Cap/Depr | 1442.16% | ||
Cap/Sales | 202.56% | ||
Interest Coverage | 250 | ||
Cash Conversion | 166.44% | ||
Profit Quality | N/A | ||
Current Ratio | 2.28 | ||
Quick Ratio | 1.97 | ||
Altman-Z | 3.73 |